Research ArticleOriginal Article
Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer
Jun Zhang, Bei Sun, Xianhui Ruan, Xiukun Hou, Jingtai Zhi, Xiangrui Meng, Xiangqian Zheng and Ming Gao
Cancer Biology & Medicine February 2021, 18 (1) 105-119; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0098
Jun Zhang
1Department of Breast Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Bei Sun
2Department of Outpatient Office, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Xianhui Ruan
3Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Xiukun Hou
3Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Jingtai Zhi
3Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Xiangrui Meng
4Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Xiangqian Zheng
3Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Ming Gao
3Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
References
- 1.↵
- Allemani C,
- Weir HK,
- Carreira H,
- Harewood R,
- Spika D,
- Wang XS, et al.
- 2.
- 3.↵
- 4.↵
- Reck M,
- Heigener DF,
- Mok T,
- Soria JC,
- Rabe KF.
- 5.
- 6.↵
- Vansteenkiste J,
- De Ruysscher D,
- Eberhardt WEE,
- Lim E,
- Senan S,
- Felip E, et al.
- 7.↵
- Winther-Larsen A,
- Nissen PH,
- Jakobsen KR,
- Demuth C,
- Sorensen BS,
- Meldgaard P.
- 8.↵
- Lim KH,
- Counter CM.
- 9.↵
- Roberts PJ,
- Der CJ.
- 10.↵
- Melegari M,
- Scaglioni PP,
- Wands JR.
- 11.↵
- Li N,
- Wang YX,
- Che SL,
- Yang Y,
- Piao JJ,
- Liu SP, et al.
- 12.
- Li XG,
- Liu SP.
- 13.↵
- Wang Y,
- Fang RP,
- Cui M,
- Zhang WY,
- Bai X,
- Wang HW, et al.
- 14.
- 15.↵
- Zhao Y,
- Li H,
- Zhang YY,
- Li LL,
- Fang RP,
- Li YH, et al.
- 16.↵
- Marusawa H,
- Matsuzawa S,
- Welsh K,
- Zou H,
- Armstrong R,
- Tamm I, et al.
- 17.↵
- Fujii R,
- Zhu CJ,
- Wen YF,
- Marusawa H,
- Bailly-Maitre B,
- Matsuzawa S, et al.
- 18.↵
- Wen YF,
- Golubkov VS,
- Strongin AY,
- Jiang W,
- Reed JC.
- 19.↵
- 20.
- Liu S,
- Li L,
- Zhang Y,
- Zhang Y,
- Zhao Y,
- You X, et al.
- 21.↵
- Xu F,
- You X,
- Liu F,
- Shen X,
- Yao Y,
- Ye L, et al.
- 22.↵
- Yue L,
- Li L,
- Liu F,
- Hu N,
- Zhang W,
- Bai X, et al.
- 23.↵
- Bar-Peled L,
- Schweitzer LD,
- Zoncu R,
- Sabatini DM.
- 24.↵
- Li XM,
- Ruan XH,
- Zhang PT,
- Yu Y,
- Gao M,
- Yuan SK, et al.
- 25.↵
- de Araujo MEG,
- Naschberger A,
- Furnrohr BG,
- Stasyk T,
- Dunzendorfer-Matt T,
- Lechner S, et al.
- 26.↵
- 27.
- Kandoth C,
- McLellan MD,
- Vandin F,
- Ye K,
- Niu BF,
- Lu C, et al.
- 28.
- Kondo T,
- Ezzat S,
- Asa SL.
- 29.↵
- 30.↵
- 31.↵
- Doebele RC,
- Pilling AB,
- Aisner DL,
- Kutateladze TG,
- Le AT,
- Weickhardt AJ, et al.
- 32.
- 33.↵
- 34.↵
- Cuevas BD,
- Abell AN,
- Witowsky JA,
- Yujiri T,
- Johnson NL,
- Kesavan K, et al.
- 35.↵
- Maruyama T,
- Kadowaki H,
- Okamoto N,
- Nagai A,
- Naguro I,
- Matsuzawa A, et al.
- 36.↵
- 37.↵
- 38.↵
- Nada S,
- Hondo A,
- Kasai A,
- Koike M,
- Saito K,
- Uchiyama Y, et al.
- 39.↵
- 40.↵
- Teis D,
- Wunderlich W,
- Huber LA.
- 41.
- Teis D,
- Taub N,
- Kurzbauer R,
- Hilber D,
- de Araujo ME,
- Erlacher M, et al.
- 42.↵
- Teis D,
- Huber LA.
In this issue
Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer
Jun Zhang, Bei Sun, Xianhui Ruan, Xiukun Hou, Jingtai Zhi, Xiangrui Meng, Xiangqian Zheng, Ming Gao
Cancer Biology & Medicine Feb 2021, 18 (1) 105-119; DOI: 10.20892/j.issn.2095-3941.2020.0098
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.